Info Edge share pricewas in focus on Tuesday after the company unveiled the performance of its artificial intelligence (AI) and deeptech investment portfolio, highlighting significant value creation from its early-stage bets on emerging technologies.
In a letter to shareholders, Info Edge said it has invested ₹614 crore across 28 AI startups, with the portfolio now valued at ₹1,268 crore. The investments have generated a 2.1x multiple on invested capital and a gross internal rate of return (IRR) of nearly 31%, reflecting the growing success of the company's AI-focused strategy.
The update provided a fresh trigger for Info Edge share price, as investors with a demat account assessed the company's ability to generate returns beyond its core internet businesses.
According to the company, 15 of the 28 AI startups in its portfolio have raised externally led follow-on funding rounds from leading global investors, including Insight Partners, Left Lane Capital, Peak XV Partners, SIG and Vertex.
The strong investor participation signals growing confidence in the startups backed by Info Edge and validates its strategy of identifying promising businesses at an early stage.
Since 2020, Info Edge has invested ₹1,003 crore across 54 AI and deeptech startups through direct investments and alternative investment funds (AIFs).
The company said many of these investments were made before the recent boom in AI-related funding. Its portfolio spans several high-growth sectors, including enterprise AI, robotics, semiconductors, spacetech, biotechnology and electric mobility.
Management noted that the investments were made during the early stages of innovation and product development, positioning the company to benefit from future value creation.
Info Edge's deeptech portfolio comprises 30 startups with a cumulative investment of ₹455 crore. These investments are currently valued at ₹559 crore, translating into a 1.2x multiple on invested capital and a gross IRR of around 15%.
Additionally, 13 deeptech companies have secured externally led funding rounds from institutional investors and sovereign-backed programs, providing further validation of the portfolio.
Read more: Pharma Stocks Rally: Nifty Pharma Rises 2% as Dr Reddy's, Sun Pharma and Cipla Lead Rally.
The latest disclosure highlights how Info Edge is building a diversified technology investment platform alongside its core operations. With its AI portfolio delivering strong returns and deeptech investments gaining institutional backing, Info Edge share price is likely to remain on investors' radar as the company continues to capitalize on India's growing innovation ecosystem.
Read stock market news in Hindi. Head to Angel One's share market news in Hindi for comprehensive coverage.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jun 23, 2026, 12:03 PM IST
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
